Suppr超能文献

RNA 干扰下调 c-Met 表达抑制人肝癌细胞生长和侵袭。

Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.

机构信息

Department of Hepatobiliary Surgery, Daping Hospital and the Field Surgery Research Institute, Third Military Medical University, Chongqing, China.

出版信息

J Surg Res. 2010 Aug;162(2):231-8. doi: 10.1016/j.jss.2009.04.030. Epub 2009 May 19.

Abstract

BACKGROUND

Cell migration is a basis for invasion and metastasis of malignant tumors. Receptor tyrosine kinases are recognized as important therapeutic targets in antineoplastic strategies. C-met is a receptor tyrosine kinase highly expressed in human hepatocellular carcinoma (HCC) cell line MHCC97-H. Higher expression of c-met in tumor tissue can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventually, metastasis. To explore the roles of c-met in modulating the motility of cell, we silenced c-met expression in the HCC line MHCC97-H by RNA interference (RNAi).

MATERIALS AND METHODS

For transient expression, c-met-siRNA 1,2 recombinant plasmids were transfected into phoenix A cells. The MHCC97-H cells were cultured in Dulbecco's modified Eagles's medium (DMEM) with 10% fetal bovine serum (FBS) to establish MHCC97-H HCC cells stably expressing c-met-siRNA. MHCC97-H cells were treated with the recombinant virus for assay of c-met mRNA and protein, evaluation of growth and invasion of MHCC97-H cells, and identification of hepatitis B virus X (HBX) protein correlation with c-met.

RESULTS

After transfection of c-met-siRNA for 48 h, the expression of c-met decreased markedly in MHCC97-H cells; the most effective site of the siRNA target sequence is at the 537 upstream, far from the transcription start. In addition, the proliferation, motility, and invasive ability of MHCC97-H cells were significantly inhibited. Furthermore, we showed that hepatitis B virus (HBV) X protein (HBX) potentiated the activities of the extracellular signal-regulated kinase 1/2 (ERK1/2) in MHCC97-H cells. Treatment with extracellular signal-regulated kinase (ERK) inhibitor (U0126), but not P38 MAPK inhibitor (SB203580) or phosphatidylinositol 3-kinase (PI3K) inhibitor (wortmannin), markedly suppressed the expression of c-met protein in MHCC97-H cells.

CONCLUSION

These results indicate that the over-expression of c-met protein plays an important role in the cell invasion of MHCC97-H, and HBX protein may promote the expression of c-met by ERKs pathway.

摘要

背景

细胞迁移是恶性肿瘤侵袭和转移的基础。受体酪氨酸激酶被认为是抗肿瘤策略中重要的治疗靶点。C-met 是一种在人肝癌细胞系 MHCC97-H 中高度表达的受体酪氨酸激酶。肿瘤组织中 c-met 的高表达可导致细胞散射、血管生成、增殖、增强细胞迁移、侵袭,最终转移。为了探讨 c-met 在调节细胞运动中的作用,我们通过 RNA 干扰(RNAi)沉默肝癌细胞系 MHCC97-H 中的 c-met 表达。

材料和方法

为了瞬时表达,将 c-met-siRNA1、2 重组质粒转染到 phoenix A 细胞中。MHCC97-H 细胞在含 10%胎牛血清(FBS)的 Dulbecco's 改良 Eagles 培养基(DMEM)中培养,建立稳定表达 c-met-siRNA 的 MHCC97-H HCC 细胞。用重组病毒处理 MHCC97-H 细胞,检测 c-metmRNA 和蛋白表达,评估 MHCC97-H 细胞的生长和侵袭能力,以及鉴定乙型肝炎病毒 X(HBX)蛋白与 c-met 的相关性。

结果

转染 c-met-siRNA 48 小时后,MHCC97-H 细胞中 c-met 的表达明显下降;siRNA 靶序列的最有效部位在 537 上游,远离转录起始点。此外,MHCC97-H 细胞的增殖、迁移和侵袭能力明显受到抑制。此外,我们表明乙型肝炎病毒(HBV)X 蛋白(HBX)增强了 MHCC97-H 细胞中细胞外信号调节激酶 1/2(ERK1/2)的活性。用细胞外信号调节激酶(ERK)抑制剂(U0126)处理,但不用 p38MAPK 抑制剂(SB203580)或磷脂酰肌醇 3-激酶(PI3K)抑制剂(wortmannin)处理,可显著抑制 MHCC97-H 细胞中 c-met 蛋白的表达。

结论

这些结果表明,c-met 蛋白的过表达在 MHCC97-H 细胞的侵袭中起重要作用,HBX 蛋白可能通过 ERKs 通路促进 c-met 的表达。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验